Human Infection with Ascaris lumbricoides Is Associated with Suppression of the Interleukin-2 Response to Recombinant Cholera Toxin B Subunit following Vaccination with the Live Oral Cholera Vaccine CVD 103-HgR - Cooper, Philip J.; Chico, Martha; Sandoval, Carlos; Espinel, Ivan; Guevara, Angel; Levine, Myron M.; Griffin, George E.; Nutman, Thomas B. (Infection and Immunity, 2001)
Keywords: Adult; Albendazole - therapeutic use; Animals; Anthelmintics - therapeutic use; Antigens, Helminth - immunology; Ascariasis - drug therapy; Ascariasis - immunology; Ascaris lumbricoides; Ascaris lumbricoides - drug effects; Ascaris lumbricoides - immunology; Bacteriology; Biological and medical sciences; Cholera - prevention & control; Cholera Toxin - immunology; Cholera Vaccines - immunology; Cholera Vaccines - therapeutic use; Double-Blind Method; Female; Fundamental and applied biological sciences. Psychology; Fungal and Parasitic Infections; Humans; Interferon-gamma - blood; Interleukin-2 - blood; Leukocytes, Mononuclear - immunology; Male; Microbiology; Pathogenicity, virulence, toxins, bacteriocins, pyrogens, host-bacteria relations, miscellaneous strains; toxin B; Vaccination; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies; Ascaris lumbricoides; Vision disorder; Suppression; Vaccination; Vibrio cholerae; Helper cell; Potential; Subunit; Association; Interleukin 2; Bacteria; Nematoda; Human; Cytokine; Vaccine; Parasitosis; Helminthiasis; Infection; Ascariasis; Toxin; Eye disease; Benzimidazole derivatives; Nematode disease; Blindness; Bacteriosis; Helmintha; Vibrionaceae; Nemathelminthia; Cholera; Invertebrata